TTC Oncology
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(952) 484-1017Website
www.ttconcology.comRevenue
$5.6 MillionIndustry
About TTC Oncology
TTC Oncology Org Chart
Is TTC Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if TTC Oncology had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when TTC Oncology launches new products
TTC Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on TTC Oncology recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if TTC Oncology is spiking on competitors!
Check if TTC Oncology has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once TTC Oncology has new funding data
Congratulate Masked Content for being promoted to Masked Content at TTC Oncology
Recommended Actions
Find VP level buyers at TTC Oncology
Find more new buyers
Compare Similar Companies to TTC Oncology
Compare insights from companies similar to TTC Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TTC Oncology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
TTC Oncology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about TTC Oncology.
TTC Oncology Tech Stack
A closer look at the technologies used by TTC Oncology
TTC Oncology News & Media
Lantern Pharma and TTC Oncology Establish AI Collaboration to Expand the Clinical Development of Drug Candidate TTC-352
DALLAS--(BUSINESS WIRE)---- $LTRN--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it has entered into a research and development collaboration with TTC Oncology. The collaboration will focus on leveraging RADR® AI insights to advance TTC Oncology’s first- and best-TTC Oncology Launches Equity Crowdfunding Campaign on WeFunder to Support Funding of Phase 2 Clinical Trials for Breast Cancer With $100,000 Initial Investment
EDINA, Minn.--(BUSINESS WIRE)-- #breastcancerresearch--TTC Participates in ConferenceTTC Oncology to Present at Biotech Showcase(TM) Digital 2021
Chicago, Illinois--(Newsfile Corp. - January 13, 2021) - TTC Oncology ("TTC" or the "Company") CEO and CMO Arek Dudek, MD, PhD, will be participating in the Biotech Showcase virtual conference occurring January 11-15, 2021. Dr. Dudek will be providing a Company overview and update on the Company's financing needs as well as TTC's lead product candidate, TTC-352. To view the full...
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TTC Oncology
TTC Oncology LLC, founded in July 2015, focuses on innovating safer solutions for the treatment of metastatic breast cancer. The company holds a worldwide license from the University of Illinois Chicago for a novel composition aimed at therapeutic modulation of the estrogen receptor in ER+ breast cancer. Directed by equity-owning members and suppor... Read More